Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Oxygenta Pharmaceutical Ltd

NSE: SSORGS · BSE: 524636 · Pharmaceuticals & Biotechnology · 2 announcements

Share price: ₹49.61
Market cap: ₹183.5 Cr
Revenue (annual): ₹113.0 Cr
Net profit (annual): ₹-17.57 Cr
P/E (TTM): -13.5×Sector 50.4×
Promoter holding: 56.54%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 18:06 IST BSE

Financial Results

Oxygenta Pharmaceutical Q1 FY27 Results: Net Loss of ₹2.1 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹37 Cr (+145.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.

Key figure: Net loss ₹2.1 Cr

Open full results → Read the filing ↗

23 May 2026 17:36 IST BSE

Financial Results

Oxygenta Pharmaceutical Q4 FY26 Results: Net Loss of ₹1.7 Cr, Loss Narrows

Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹49.6 Cr (+0.2% YoY) and a net loss of ₹1.7 Cr for Q4 FY26.

Key figure: Net loss ₹1.7 Cr

Open full results → Read the filing ↗